CymitQuimica logo
c-Met / HGFR

c-Met / HGFR

Los inhibidores de c-Met/HGFR apuntan al Receptor del Factor de Crecimiento de Hepatocitos (c-Met), una tirosina quinasa involucrada en procesos celulares como el crecimiento, la motilidad y la morfogénesis. La señalización de c-Met está implicada en la progresión del cáncer, la metástasis y la resistencia a terapias. Inhibir c-Met puede interrumpir el crecimiento y la propagación del tumor, lo que hace que estos inhibidores sean valiosos en la investigación del cáncer. En CymitQuimica, ofrecemos inhibidores de c-Met/HGFR para apoyar su investigación en oncología, metástasis y terapias contra el cáncer dirigidas.

Productos de "c-Met / HGFR"

Ordenar por

productos por página.Hay 91 productos en esta categoría.
  • Canlitinib

    CAS:
    Canlitinib, a tyrosine kinase inhibitor, holds potential for cancer research.
    Fórmula:C33H31F2N3O7
    Pureza:98%
    Forma y color:Solid
    Peso molecular:619.61

    Ref: TM-T78206

    5mg
    A consultar
    50mg
    A consultar
  • SRI 31215 TFA

    CAS:
    SRI 31215 TFA acts as a triplex inhibitor of matriptase, hepsin and HGFA and mimics the activity of HAI-1/2, endogenous inhibitors of HGF activation.
    Fórmula:C27H34F3N5O3
    Pureza:98.25% - 99.97%
    Forma y color:Solid
    Peso molecular:533.6

    Ref: TM-T5478

    1mg
    43,00€
    5mg
    96,00€
    10mg
    135,00€
    25mg
    261,00€
    50mg
    391,00€
    100mg
    557,00€
    200mg
    753,00€
    1mL*10mM (DMSO)
    101,00€
  • 1D228


    1D228, a c-Met/TRK inhibitor with antitumor properties, suppresses cyclin D1 to precipitate G0/G1 arrest, thereby inhibiting proliferation and migration of
    Pureza:98%
    Forma y color:Odour Solid

    Ref: TM-T83433

    5mg
    A consultar
    50mg
    A consultar
  • CEP-40783

    CAS:
    CEP-40783 (RXDX-106) is an effective, specific and orally active AXL/c-Met inhibitor (IC50: 7/12 nM). It also inhibits MER and TYRO3 (IC50: 29/19 nM).
    Fórmula:C31H26F2N4O6
    Pureza:99.45% - 99.64%
    Forma y color:Solid
    Peso molecular:588.56

    Ref: TM-T4426

    5mg
    50,00€
    10mg
    80,00€
    25mg
    170,00€
    50mg
    210,00€
    100mg
    304,00€
    200mg
    437,00€
  • Merestinib

    CAS:
    Merestinib (LY2801653) is an orally available, small molecule inhibitor of the proto-oncogene c-Met (Ki: 2 nM) with potential antineoplastic activity.
    Fórmula:C30H22F2N6O3
    Pureza:95% - 99.56%
    Forma y color:Solid
    Peso molecular:552.53

    Ref: TM-T3455

    1mg
    49,00€
    2mg
    70,00€
    5mg
    105,00€
    10mg
    144,00€
    25mg
    254,00€
    50mg
    424,00€
    100mg
    605,00€
    500mg
    1.264,00€
    1mL*10mM (DMSO)
    126,00€
  • PF-04217903

    CAS:
    MET Tyrosine Kinase Inhibitor PF-04217903 is an orally bioavailabe, small-molecule tyrosine kinase inhibitor with potential antineoplastic activity.
    Fórmula:C19H16N8O
    Pureza:98.41% - 98.55%
    Forma y color:Solid
    Peso molecular:372.38

    Ref: TM-T2676

    1mg
    38,00€
    2mg
    49,00€
    5mg
    73,00€
    10mg
    97,00€
    25mg
    172,00€
    50mg
    288,00€
    100mg
    520,00€
    1mL*10mM (DMSO)
    79,00€
  • Afatinib

    CAS:
    Afatinib (BIBW 2992) is an irreversible and orally EGFR family inhibitor that inhibits EGFR and HER2. Afatinib has antitumor activity. Cost effective and quality assured.
    Fórmula:C24H25ClFN5O3
    Pureza:97.56% - 99.9%
    Forma y color:Off-White Solid
    Peso molecular:485.94

    Ref: TM-T21312

    5mg
    35,00€
    10mg
    51,00€
    25mg
    86,00€
    50mg
    115,00€
    100mg
    144,00€
    200mg
    177,00€
    500mg
    300,00€
    1mL*10mM (DMSO)
    52,00€
  • PROTAC c-Met degrader-1

    CAS:
    PROTACc-Met degrader-1 (Compound Met-DD4) is an orally effective PROTAC degrader targeting c-Met with a DC50 of 6.21 nM. It inhibits the proliferation of c-Met-addicted MKN-45 cells with an IC50 of 4.37 nM and causes cell cycle arrest in the G0/G1 phase. In a xenograft mouse model using MKN-45 cells, PROTACc-Met degrader-1 demonstrates antitumor activity.
    Fórmula:C45H41FN10O5
    Forma y color:Solid
    Peso molecular:820.87

    Ref: TM-T201057

    10mg
    A consultar
    50mg
    A consultar
  • Onartuzumab

    CAS:
    Onartuzumab (MetMAb) is a humanized monoclonal antibody targeting c-MET, with antitumor effects by blocking HGF and signal transduction.
    Pureza:97.3%
    Forma y color:Liquid
    Peso molecular:146.99 kDa

    Ref: TM-T76780

    1mg
    427,00€
    5mg
    1.768,00€
    10mg
    2.365,00€
  • Emibetuzumab

    CAS:
    Emibetuzumab: potent humanized MET antibody, antitumor, inhibits HGF/MET pathways, for advanced prostate cancer research.
    Pureza:SDS-PAGE:96.2%;SEC-HPLC:98.8%
    Forma y color:Liquid
    Peso molecular:143.74 kDa

    Ref: TM-T76743

    1mg
    144,00€
    5mg
    424,00€
    10mg
    677,00€
  • Cabozantinib

    CAS:
    Cabozantinib (XL184) is a multi-targeted tyrosine kinase receptor inhibitor that inhibits VEGFR2, c-Met, Kit, Axl, and Flt3 (IC50=0.035/1.3/4.6/7/11.3 nM).
    Fórmula:C28H24FN3O5
    Pureza:99.59% - 99.88%
    Forma y color:Solid
    Peso molecular:501.51

    Ref: TM-T2586

    5mg
    47,00€
    10mg
    60,00€
    50mg
    79,00€
    100mg
    96,00€
    200mg
    153,00€
    500mg
    249,00€
    1mL*10mM (DMSO)
    50,00€
  • Crizotinib hydrochloride

    CAS:
    Crizotinib hydrochloride (PF-02341066 hydrochloride) is a novel inhibitor of anaplastic lymphoma kinase and c-Met(IC50s of 20 and 8 nM)
    Fórmula:C21H23Cl3FN5O
    Pureza:98.73% - 98.87%
    Forma y color:Solid
    Peso molecular:486.8

    Ref: TM-T8399

    5mg
    37,00€
    10mg
    52,00€
    25mg
    82,00€
    50mg
    99,00€
    100mg
    138,00€
    200mg
    171,00€
    500mg
    227,00€
    1mL*10mM (DMSO)
    59,00€
  • c-met-IN-1

    CAS:
    c-met-IN-1 is a potent and selective c-Met inhibitor (IC50: 1.1 nM) with antitumor activity.
    Fórmula:C35H37FN6O5
    Pureza:98%
    Forma y color:Solid
    Peso molecular:640.7

    Ref: TM-T10653

    25mg
    1.730,00€
    50mg
    2.262,00€
    100mg
    2.945,00€
  • Hepln-13

    CAS:
    Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.
    Fórmula:C17H13BrN2
    Pureza:97.67%
    Forma y color:Solid
    Peso molecular:325.2

    Ref: TM-T25492

    1mg
    38,00€
    2mg
    50,00€
    5mg
    85,00€
    10mg
    126,00€
    25mg
    245,00€
    50mg
    364,00€
    100mg
    507,00€
    200mg
    700,00€
    1mL*10mM (DMSO)
    96,00€
  • Crizotinib

    CAS:
    Crizotinib (PF-02341066) is an ATP-competitive small-molecule tyrosine kinases inhibitor of c-MET (IC50: 8 nM) and ALK (IC50: 20 nM) receptor.
    Fórmula:C21H22Cl2FN5O
    Pureza:99% - 99.87%
    Forma y color:Solid
    Peso molecular:450.34

    Ref: TM-T1661

    10mg
    50,00€
    25mg
    60,00€
    50mg
    69,00€
    100mg
    93,00€
    200mg
    97,00€
    500mg
    156,00€
    1mL*10mM (DMSO)
    52,00€
  • Narnatumab

    CAS:
    Narnatumab (IMC-RON8) is a humanized antibody targeting the macrophage-stimulating receptor (RON) with antitumor activity, used in advanced malignant solid tumors research.
    Forma y color:Liquid

    Ref: TM-T77409

    1mg
    460,00€
    5mg
    1.418,00€
    10mg
    2.196,00€
    25mg
    4.126,00€
  • SYN1143

    CAS:
    SYN1143 (AMG-1) strongly inhibits RON & c-Met with IC50s: 9 & 4 nmol/L.
    Fórmula:C31H29FN4O5
    Pureza:98.86%
    Forma y color:Solid
    Peso molecular:556.58

    Ref: TM-T8409

    2mg
    35,00€
    5mg
    52,00€
    10mg
    81,00€
    25mg
    117,00€
    50mg
    170,00€
    1mL*10mM (DMSO)
    65,00€
  • SU11274

    CAS:
    SU11274 (Met Kinase Inhibitor)(IC50=10 nM) is a specific Met inhibitor. It shows no significant effects on PGDFRβ, EGFR or Tie2.
    Fórmula:C28H30ClN5O4S
    Pureza:98.62% - 99.44%
    Forma y color:Orange Powder
    Peso molecular:568.09

    Ref: TM-T6154

    1mg
    47,00€
    2mg
    59,00€
    5mg
    97,00€
    10mg
    150,00€
    25mg
    283,00€
    50mg
    465,00€
    100mg
    688,00€
    1mL*10mM (DMSO)
    150,00€
  • SAR125884 hydrochlorid (1116743-46-4(free base))

    CAS:
    SAR125844 is a potent and selective MET kinase inhibitor with a favorable preclinical toxicity profile,(IC50=4.2 nM).
    Fórmula:C25H23FN8O2S2·HCl
    Pureza:97.95%
    Forma y color:Solid
    Peso molecular:587

    Ref: TM-T5677

    1mg
    38,00€
    5mg
    60,00€
    10mg
    90,00€
    25mg
    188,00€
    50mg
    279,00€
    100mg
    395,00€
    200mg
    567,00€
    1mL*10mM (DMSO)
    101,00€
  • Glumetinib

    CAS:
    Glumetinib (SCC244) (SCC 244) is a novel potent and selective inhibitor of c-Met kinase (IC50: 0.42 nM).
    Fórmula:C21H17N9O2S
    Pureza:99.79%
    Forma y color:Solid
    Peso molecular:459.48

    Ref: TM-T5414

    1mg
    55,00€
    5mg
    111,00€
    10mg
    170,00€
    25mg
    278,00€
    50mg
    415,00€
    100mg
    613,00€